Vaahtoranta-Lehtonen H H, Lehtonen O P, Peltola O
Finnsusp Ltd., Lieto, Finland.
CLAO J. 1997 Oct;23(4):270-4.
We compared Ethyl-6-O-decanoyl-glucoside 0.005% (EDG) combined with 0.00025% chlorhexidine acetate (EDGC) to a commercial polyaminpropylbiguanide (PAPB).
Fifty-nine subjects wearing both ionic and non-ionic contact lenses for 8-16 hours daily used either EDGC or PAPB as a cleaning and disinfectant agent. Neither mechanical nor separate cleaning agents were employed. The study period was for 8 weeks. The following symptoms were compared for each solution: blurred vision, dryness, foreign body sensation, redness, and dirty lenses. The following signs were also compared for each solution: conjunctival hyperemia, papillary hypertrophy, corneal deposits, purulence, limbal vascularization, subepithelial scarring, visual acuity, bulbar hyperemia, and tear breakup time.
After 8 weeks, 52% of the subjects in the EDGC group showed no evidence of corneal or conjunctival abnormalities. In contrast, only 19% of the subjects in the PAPB group showed no abnormalities of the conjunctiva or cornea (P = 0.012). After 8 weeks, 25% of the EDGC group showed evidence of papillary hypertrophy, whereas 50% of the PAPB group showed similar findings (P = 0.007). In addition, after 8 weeks of wear, 21% of the subjects using EDGC had positive conjunctival cultures, whereas the rate of positive cultures in the PAPB group was 50% (P = 0.035). At the conclusion of the study, the protein contents of the lenses were 131 micrograms +/- 48 micrograms (N = 29) in the EDGC group and 185 micrograms +/- 65 micrograms (N = 26) in the PAPB group (P = 0.001).
Subjects using EDGC had fewer pathological findings than subjects using PAPB as their cleaning and disinfecting agent. The mechanism by which EDGC reduced the rate of papillary hypertrophy needs further investigation.
我们将0.005%的乙基-6-O-癸酰葡萄糖苷(EDG)与0.00025%的醋酸氯己定(EDGC)组合制剂与一种市售的聚氨基丙基双胍(PAPB)进行比较。
59名每天佩戴离子型和非离子型隐形眼镜8至16小时的受试者,使用EDGC或PAPB作为清洁和消毒剂。既不采用机械清洁也不使用单独的清洁剂。研究期为8周。比较每种溶液的以下症状:视力模糊、眼干、异物感、眼红和镜片脏污情况。还比较每种溶液的以下体征:结膜充血、乳头肥大、角膜沉积物、脓性分泌物、角膜缘血管化、上皮下瘢痕形成、视力、球结膜充血和泪膜破裂时间。
8周后,EDGC组52%的受试者未表现出角膜或结膜异常迹象。相比之下,PAPB组只有19%的受试者未出现结膜或角膜异常(P = 0.012)。8周后,EDGC组25%的受试者有乳头肥大迹象,而PAPB组50%的受试者有类似表现(P = 0.007)。此外,佩戴8周后,使用EDGC的受试者中有21%结膜培养呈阳性,而PAPB组的阳性培养率为50%(P = 0.035)。在研究结束时,EDGC组镜片的蛋白质含量为131微克±48微克(N = 29),PAPB组为185微克±65微克(N = 26)(P = 0.001)。
与使用PAPB作为清洁和消毒剂的受试者相比,使用EDGC的受试者病理表现更少。EDGC降低乳头肥大发生率的机制需要进一步研究。